Get the Stockscreener App
0.00
100.00%
-42.98
After Hours:
42.99
42.99
+
Surmodics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
See More
Previous Close:
$42.98
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$614.51M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
0.00
EPS:
0.38
Net Cash Flow:
$9.86M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$43.00
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Compare SRDX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
0.00 | 614.51M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
110.25 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
345.78 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.97 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.63 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.09 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-25 | Downgrade | Barrington Research | Mkt Perform → Underperform |
| Mar-07-25 | Upgrade | Lake Street | Hold → Buy |
| Jun-13-23 | Upgrade | Needham | Hold → Buy |
| Feb-13-23 | Downgrade | Needham | Buy → Hold |
| Jul-23-20 | Upgrade | Needham | Hold → Buy |
| Dec-11-19 | Downgrade | Needham | Buy → Hold |
| Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Lake Street | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Feb-21-19 | Reiterated | Needham | Buy |
| May-16-18 | Reiterated | Needham | Buy |
| Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-18 | Reiterated | Lake Street | Buy |
| Feb-28-18 | Initiated | Needham | Buy |
| Jul-14-17 | Initiated | Lake Street | Buy |
| Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
| May-03-16 | Reiterated | Barrington Research | Outperform |
| Aug-06-15 | Reiterated | Barrington Research | Outperform |
| Mar-27-15 | Initiated | Dougherty & Company | Buy |
| Feb-25-14 | Initiated | Laidlaw | Buy |
| Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
| Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
Aug Sectors: Can Surmodics Inc expand its profit marginsWeekly Trend Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Aug Closing: What is the cash position of Surmodics Inc2025 Stock Rankings & High Conviction Trade Alerts - baoquankhu1.vn
SRDX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Nashville InnoSurmodics adds to med-device portfolio with $39.9M acquisition of Vetex Medical - The Business Journals
Will Surmodics Inc. stock benefit from upcoming earnings reportsQuarterly Portfolio Report & Advanced Technical Analysis Signals - mfd.ru
Surmodics Buyout: Why This Quiet Medtech Deal Still Matters for US Investors - AD HOC NEWS
What hedge funds are buying Surmodics Inc.Rate Hike & Risk Managed Investment Signals - mfd.ru
Earnings Miss: What is the cash position of Surmodics Inc2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
Macro Review: Is Surmodics Inc likely to announce a buybackJuly 2025 Review & Daily Stock Momentum Reports - baoquankhu1.vn
Aug Setups: Is Surmodics Inc stock a value trapJuly 2025 Movers & Weekly Momentum Stock Picks - baoquankhu1.vn
Buybacks Report: Can Surmodics Inc expand into new markets2025 Price Targets & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Technical Analysis: Will Surmodics Inc be affected by tariffsJuly 2025 Technicals & Stepwise Swing Trade Plans - baoquankhu1.vn
Market Pulse: Is SIM Acquisition Corp I Equity Warrant benefiting from interest rate changes2025 EndofYear Setup & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Merger Talk: Is IVVD in a consolidation phase2025 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
SurModics Completes Merger, Ends Credit Agreement - MSN
Will Surmodics Inc. stock deliver shareholder valueJuly 2025 Movers & Growth Focused Stock Reports - Улправда
How risky is Surmodics Inc. stock nowDaily Trainer Picks & updated model highlights and notes - ulpravda.ru
Will Surmodics Inc. stock keep outperforming rivals2025 Market Overview & Precise Entry and Exit Recommendations - Улправда
Why Surmodics Inc. stock attracts high net worth investorsEarnings Beat & Community Trade Idea Sharing Platform - Улправда
MSN Money - MSN
Will Surmodics Inc. stock see insider buying2025 Biggest Moves & Long-Term Safe Investment Ideas - Улправда
Surmodics, Inc.Common Stock (NQ: SRDX - FinancialContent
Pasadena Star-News: Local News, Sports, Things to DoSurmodics, Inc.Common Stock (Nasdaq:SRDX) Stock Quote - FinancialContent
Surmodics falls on report about FTC review of GTCR deal - MSN
Market Review: How Surmodics Inc stock benefits from strong dollarMarket Movers & Reliable Breakout Forecasts - moha.gov.vn
Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance - ADVFN
Surmodics Reports Second Quarter Fiscal 2021 Results and Issues Fiscal 2021 Revenue and EPS Guidance - ADVFN
Surmodics, Inc. (SRDX) Stock Report: Navigating Challenges with Innovative Medical Solutions - DirectorsTalk Interviews
Surmodics (SRDX): Quiet ticker, loud implications – what the latest price action really says - AD HOC NEWS
How Surmodics Inc stock benefits from strong dollarJuly 2025 Sector Moves & Precise Trade Entry Recommendations - moha.gov.vn
Behavioral Patterns of SRDX and Institutional Flows - Stock Traders Daily
Surmodics, Inc. (SRDX) Stock Analysis: Examining Challenges Amid Healthcare Sector Volatility - DirectorsTalk Interviews
Surmodics Unveils New Division to Preserve Biocoat’s Coating Legacy - MyChesCo
Medtech Integer Could Be More Valuable As A Private CompanyActivist Investor Urges Strategic Review - Sahm
Total debt per share of SurModics, Inc. – LS:914178 - TradingView — Track All Markets
Biocoat Announces Formation of Surmodics Services & Technologies Division Following Merger and Divestiture Transactions - BioSpace
SurModics, Inc. Financial Disclosures & Filings - TradingView — Track All Markets
Surmodics, Inc. acquired certain assets from Biocoat, Incorporated. - MarketScreener
Tranche Update on Surmodics, Inc.'s Equity Buyback Plan announced on November 6, 2014. - marketscreener.com
Cash per share of SurModics, Inc. – LSX:914178 - TradingView — Track All Markets
How interest rate cuts could boost Surmodics Inc. stockJuly 2025 Levels & Precise Buy Zone Identification - Newser
SurModics: Dividend historical data and projections - marketscreener.com
How sustainable is Surmodics Inc. stock dividend payoutTreasury Yields & Stepwise Trade Signal Guides - Newser
Understanding Momentum Shifts in (SRDX) - Stock Traders Daily
GTCR/Surmodics Win On Divestiture, Share Analysis And Captive Capacity - MarketScreener
Judge Clears PE Firm’s $627M Acquisition of Medical Device Firm, a Setback for the FTC - JD Supra
[EFFECT] SURMODICS INC SEC Filing - Stock Titan
Is Surmodics Inc. stock a safe investment in uncertain marketsWeekly Trade Analysis & Accurate Technical Buy Alerts - newser.com
Will Surmodics Inc. stock recover faster than marketWeekly Trade Review & Risk Managed Investment Entry Signals - newser.com
Is Surmodics Inc. stock positioned well for digital economy2025 Big Picture & Safe Entry Zone Identification - newser.com
Private equity firm finally closes $627 million deal to acquire Surmodics - Star Tribune
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.21%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):